Abbreviations AACE/ACE: American Association of Clinical Endocrinologists/American College of Endocrinology ADA: American Diabetes Association ASCVD: Atherosclerotic cardiovascular disease AUC: Area under the curve C avg : Average plasma concentration CI: Confidence interval C max : Maximum concentration CV: Cardiovascular CVD: Cardiovascular disease CVOT: Cardiovascular outcomes trial DPP-4: Dipeptidyl peptidase-4 empa: empagliflozin ETD: Estimated treatment difference FDA: Food and Drug Administration GI: Gastrointestinal GLP-1: Glucagon-like peptide-1 GLP-1RA: Glucagon-like peptide-1 receptor agonist GRAS: Generally regarded as safe HbA 1c : Glycated hemoglobin HR: Hazard ratio imp.: impairment lira: liraglutide MACE: Major adverse cardiovascular events met: metformin OAD: Oral antidiabetes drug pbo: placebo s.c.: subcutaneous sema: semaglutide SGLT2i: Sodium-glucose co-transporter-2 inhibitor sita: sitagliptin SNAC: Sodium N-(8-[2-hydroxybenzoyl]amino)caprylate SU: Sulfonylurea t 1/2 : Terminal half-life T2D: Type 2 diabetes T max : Time to maximum concentration References Lau JL, Dunn MK
The answer to this question depends, in part, on any side effects that you experience
Where to Get Further Advice on Storing Injectable Medicines Key UK sources include your dispensing pharmacist, GP, clinical trial coordinator, the Specialist Pharmacy Service (SPS), NHS 111, and the Electronic Medicines Compendium (EMC)
The test identifies your inherited variations in GLP-1 receptor pathways, GIPR signaling, metabolic genes, and appetite regulation across 150+ genetic insights
